Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suprachoroidal vs Intravitreal Bevacizumab in Diabetic Macular Edema
NCT07897630Phase 3Enrolling by invitation
- Sponsor
- Khyber Teaching Hospital
- Start
- Oct 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in diabetic macular edema (DME), sponsored by Khyber Teaching Hospital. Started Oct 2026; status: enrolling by invitation.
02
Drugs
bevacizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT07897630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07897630.